Clinical experience with eplerenone to treat chronic central serous chorioretinopathy

被引：0
|
作者：
Bertan Cakir
Franziska Fischer
Christoph Ehlken
Anima Bühler
Andreas Stahl
Günther Schlunck
Daniel Böhringer
Hansjürgen Agostini
Clemens Lange
机构：
[1] University of Freiburg,Eye Center, Medical Center, Faculty of Medicine
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2016年 / 254卷
关键词：
Central serous chorioretinopathy; Eplerenone; Subretinal fluid; Central macular thickness; Mineralocorticoid antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2151 / 2157
页数：6
相关论文
共 50 条
  • [21] Reply to: ‘Current perspectives on the use of eplerenone for chronic central serous chorioretinopathy’
    Andrew Lotery
    Sobha Sivaprasad
    Abby O’Connell
    Barnaby Reeves
    Eye, 2021, 35 : 3448 - 3448
  • [22] Oral Eplerenone for Treatment of Chronic Central Serous Chorioretinopathy: A Case Series
    Salz, David A.
    Pitcher, John D., III
    Hsu, Jason
    Regillo, Carl D.
    Fineman, Mitchell S.
    Elliott, Kevin S.
    Vander, James F.
    Fischer, David H.
    Spirn, Marc J.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (04): : 439 - 444
  • [23] The effect of eplerenone in chronic central serous chorioretinopathy refractory to PDT therapy
    Parikakis, E.
    Karagiannis, D.
    Batsos, G.
    Kontomihos, L.
    Ktena, E.
    Peponis, V.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 94 - 94
  • [24] Effects of Eplerenone as a Treatment Option for Patients with Chronic Central Serous Chorioretinopathy
    Luda, Robert
    Frank, Christiane
    Feucht, Nikolaus
    Lohmann, Chris
    Maier, Mathias
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [25] Reply to: 'Current perspectives on the use of eplerenone for chronic central serous chorioretinopathy'
    Lotery, Andrew
    Sivaprasad, Sobha
    O'Connell, Abby
    Reeves, Barnaby
    EYE, 2021, 35 (12) : 3448 - 3448
  • [26] Eplerenone for Treatment of Chronic Central Serous Chorioretinopathy: A Retrospective Case Series
    Greven, Margaret
    Salz, David
    Pitcher, John D.
    Elliot, Kevin
    Regillo, Carl D.
    Fineman, Mitchell
    Hsu, Jason
    Vander, James F.
    Fischer, David H.
    Spirn, Marc
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [27] The Effect of Eplerenone in Chronic Central Serous Chorioretinopathy Refractory to Photodynamic Therapy
    Karagiannis, Dimitrios
    Parikakis, Efstratios
    Kontomichos, Loukas
    Batsos, Georgios
    Chatziralli, Irini
    SEMINARS IN OPHTHALMOLOGY, 2019, 34 (06) : 436 - 441
  • [28] The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy
    Breukink, Myrte B.
    den Hollander, Anneke I.
    Keunen, Jan E. E.
    Boon, Camiel J. F.
    Hoyng, Carel B.
    ACTA OPHTHALMOLOGICA, 2014, 92 (06) : E488 - E490
  • [29] CENTRAL SEROUS CHORIORETINOPATHY - TO TREAT OR NOT TO TREAT
    DELAEY, JJ
    DOCUMENTA OPHTHALMOLOGICA, 1986, 61 (3-4) : 367 - 372
  • [30] Eplerenone in the treatment of active central serous chorioretinopathy
    Boundaoui, Oussama
    Chon, Andrew
    Davis, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
12345